{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:23Z","timestamp":1793900483043,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022ZD21"],"award-info":[{"award-number":["ZR2022ZD21"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Liver fibrosis is a major pathological consequence of chronic liver injury, and carvedilol, a drug effective in reducing portal hypertension, has been shown to exert anti-fibrotic effects in recent studies, yet the precise molecular mechanism underlying this activity remains elusive. This study aimed to investigate the core scientific question of whether carvedilol alleviates liver fibrosis by inducing ferroptosis in hepatic stellate cells (HSCs) and to clarify the corresponding regulatory mechanisms. Using a CCl\n                    <jats:sub>4<\/jats:sub>\n                    -induced mouse liver fibrosis model and human (LX-2)\/rat (HSC-T6) HSC lines treated with carvedilol, mechanistic analyses were conducted via Western blot, quantitative real-time PCR (RT-qPCR), RNA sequencing (RNA-seq), chromatin immunoprecipitation (ChIP), as well as functional assays involving genetic manipulation and pharmacological inhibitors. Carvedilol significantly attenuated HSCs activation and ameliorated liver fibrosis in mice, and it induced ferroptosis in HSCs\u2014characterized by mitochondrial shrinkage, lipid peroxidation, and iron accumulation\u2014an effect that was abrogated by the ferroptosis inhibitor ferrostatin-1. Mechanistically, carvedilol triggered endoplasmic reticulum (ER) stress to activate the PERK\/eIF2\u03b1\/ATF4 signaling axis, and ATF4 transcriptionally upregulated spermidine\/spermine N1-acetyltransferase 1 (SAT1). Ectopic overexpression of SAT1 alone was sufficient to induce ferroptosis and suppress HSCs activation, whereas SAT1 knockdown completely abolished the aforementioned effects of carvedilol. Importantly, SAT1 catalyzed spermidine depletion, which led to the post-transcriptional downregulation of GPX4 and xCT proteins, and exogenous spermidine supplementation effectively rescued SAT1-overexpression-induced ferroptosis in HSCs. Collectively, our findings demonstrate that carvedilol ameliorates liver fibrosis by inducing HSCs ferroptosis via the ER stress\/ATF4\/SAT1\/spermidine depletion axis. This study identifies a novel regulatory role of spermidine metabolism in HSCs ferroptosis and liver fibrogenesis, and further establishes spermidine metabolism as a potential and specific therapeutic target for fibrotic liver diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08898-5","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:28:40Z","timestamp":1779431320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Carvedilol triggers ferroptosis in hepatic stellate cells via the ATF4\/SAT1 axis promoting spermidine depletion to ameliorate liver fibrosis"],"prefix":"10.1038","volume":"17","author":[{"given":"Yifu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8711-1579","authenticated-orcid":false,"given":"Chunqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"8898_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8898_CR2","doi-asserted-by":"crossref","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9:875.","DOI":"10.3390\/cells9040875"},{"key":"8898_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830\u201341.","journal-title":"Gut"},{"key":"8898_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8898_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"8898_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/j.2040-4603.2013.tb00494.x","volume":"3","author":"ER Anderson","year":"2013","unstructured":"Anderson ER, Shah YM. Iron homeostasis in the liver. Compr Physiol. 2013;3:315\u201330.","journal-title":"Compr Physiol"},{"key":"8898_CR7","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"8898_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130\u201343.","journal-title":"Free Radic Biol Med"},{"key":"8898_CR9","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1002\/ptr.7558","volume":"36","author":"G Liu","year":"2022","unstructured":"Liu G, Wei C, Yuan S, Zhang Z, Li J, Zhang L, et al. Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1\/P53\/SLC7A11 pathway. Phytother Res. 2022;36:4230\u201343.","journal-title":"Phytother Res"},{"key":"8898_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102435","volume":"56","author":"L Li","year":"2022","unstructured":"Li L, Wang K, Jia R, Xie J, Ma L, Hao Z, et al. Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation. Redox Biol. 2022;56:102435.","journal-title":"Redox Biol"},{"key":"8898_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.14218\/JCTH.2023.00162","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li Y, Qiu Y, Shen M, Wang L, Shao J, et al. Artesunate induces ferroptosis in hepatic stellate cells and alleviates liver fibrosis via the ROCK1\/ATF3 axis. J Clin Transl Hepatol. 2024;12:36\u201351.","journal-title":"J Clin Transl Hepatol"},{"key":"8898_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1135366","volume":"14","author":"L Xu","year":"2023","unstructured":"Xu L, Zhang M, Pan J, Xu X, Zhang Y, Han X, et al. Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway. Front Pharmacol. 2023;14:1135366.","journal-title":"Front Pharmacol"},{"key":"8898_CR13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VIIF. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76:959\u201374.","journal-title":"J Hepatol"},{"key":"8898_CR14","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2147\/DDDT.S210797","volume":"13","author":"Y Wu","year":"2019","unstructured":"Wu Y, Li Z, Xiu AY, Meng DX, Wang SN, Zhang CQ. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice. Drug Des Devel Ther. 2019;13:2667\u201376.","journal-title":"Drug Des Devel Ther"},{"key":"8898_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.biopha.2018.10.005","volume":"108","author":"D Meng","year":"2018","unstructured":"Meng D, Li Z, Wang G, Ling L, Wu Y, Zhang C. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomed Pharmacother. 2018;108:1617\u201327.","journal-title":"Biomed Pharmacother"},{"key":"8898_CR16","first-page":"1605","volume":"20","author":"L Ling","year":"2019","unstructured":"Ling L, Li G, Wang G, Meng D, Li Z, Zhang C. Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis. Mol Med Rep. 2019;20:1605\u201312.","journal-title":"Mol Med Rep"},{"key":"8898_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7932046","volume":"2019","author":"Y Wu","year":"2019","unstructured":"Wu Y, Li Z, Wang S, Xiu A, Zhang C. Carvedilol inhibits angiotensin II-induced proliferation and contraction in hepatic stellate cells through the RhoA\/Rho-kinase pathway. Biomed Res Int. 2019;2019:7932046.","journal-title":"Biomed Res Int"},{"key":"8898_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/path.6076","volume":"260","author":"M Matareed","year":"2023","unstructured":"Matareed M, Maranou E, Koskela SA, Mehmood A, Kalirai H, Coupland SE, et al. Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities. J Pathol. 2023;260:203\u201321.","journal-title":"J Pathol"},{"key":"8898_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/tbed\/5822897","volume":"2025","author":"P Hao","year":"2025","unstructured":"Hao P, Liu Y, Cui C, Li L, Qu Q, Shang L, et al. DDX3X promotes rotavirus infection and serves as an antiviral target. Transbound Emerg Dis. 2025;2025:5822897.","journal-title":"Transbound Emerg Dis"},{"key":"8898_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ncb2738","volume":"15","author":"J Han","year":"2013","unstructured":"Han J, Back SH, Hur J, Lin Y-H, Gildersleeve R, Shan J, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol. 2013;15:481\u201390.","journal-title":"Nat Cell Biol"},{"key":"8898_CR21","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1093\/neuonc\/noaf128","volume":"27","author":"AA-OX Rana","year":"2025","unstructured":"Rana AA-OX, Horton TA-O, Thakur VS, Wang D, Thakur V, Dalzell M, et al. Polyamine acetylation mediates crosstalk between cancer cells and myeloid cells to promote mesenchymal\/plurimetabolic states in glioblastoma. Neuro Oncol. 2025;27:2574\u201391.","journal-title":"Neuro Oncol"},{"key":"8898_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173982","volume":"898","author":"S Cai","year":"2021","unstructured":"Cai S, Wu L, Yuan S, Liu G, Wang Y, Fang L, et al. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway. Eur J Pharm. 2021;898:173982.","journal-title":"Eur J Pharm"},{"key":"8898_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.taap.2013.08.009","volume":"272","author":"L Fang","year":"2013","unstructured":"Fang L, Zhan S, Huang C, Cheng X, Lv X, Si H, et al. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol Appl Pharm. 2013;272:713\u201325.","journal-title":"Toxicol Appl Pharm"},{"key":"8898_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8898_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00535-025-02300-5","volume":"60","author":"K Hino","year":"2025","unstructured":"Hino K, Nishina S, Yanatori I. Ferroptosis: biology and role in liver disease. J Gastroenterol. 2025;60:1339\u201361.","journal-title":"J Gastroenterol"},{"key":"8898_CR26","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1002\/ptr.8338","volume":"38","author":"MX Liu","year":"2024","unstructured":"Liu MX, Gu YY, Nie WY, Zhu XM, Qi MJ, Zhao RM, et al. Formononetin induces ferroptosis in activated hepatic stellate cells to attenuate liver fibrosis by targeting NADPH oxidase 4. Phytother Res. 2024;38:5988\u20136003.","journal-title":"Phytother Res"},{"key":"8898_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1182\/blood.2019002907","volume":"136","author":"Y Yu","year":"2020","unstructured":"Yu Y, Jiang L, Wang H, Shen Z, Cheng Q, Zhang P, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 2020;136:726\u201339.","journal-title":"Blood"},{"key":"8898_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41420-021-00768-7","volume":"7","author":"J Yi","year":"2021","unstructured":"Yi J, Wu S, Tan S, Qin Y, Wang X, Jiang J, et al. Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis. Cell Death Discov. 2021;7:374.","journal-title":"Cell Death Discov"},{"key":"8898_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504192","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Song XW, Zhang N, Li XH, Wu FC, Wei YA, et al. Ezetimibe-engineered L14-8 suppresses advanced prostate cancer by activating PLK1\/TP53-SAT1-induced ferroptosis. Adv Sci. 2025;12. e04192.","journal-title":"Adv Sci"},{"key":"8898_CR30","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/jat.4798","volume":"45","author":"C Zhou","year":"2025","unstructured":"Zhou C, Xu Z, Ding S, Li X, Wang H, He H, et al. Benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE) induces ferroptosis in rat cortical neurons via p53-SLC7A11-ALOX12\/p53-SAT1-ALOX15 pathways. J Appl Toxicol. 2025;45:1637\u201348.","journal-title":"J Appl Toxicol"},{"key":"8898_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116790","volume":"233","author":"T Yang","year":"2025","unstructured":"Yang T, Zhang S, Nie K, Peng X, Huo J, Fu X, et al. WWOX-mediated p53\/SAT1 and NRF2\/FPN1 axis contribute to toosendanin-induced ferroptosis in hepatocellular carcinoma. Biochem Pharmacol. 2025;233:116790.","journal-title":"Biochem Pharmacol"},{"key":"8898_CR32","doi-asserted-by":"crossref","unstructured":"Yang H, Li Y, Zhu W, Feng X, Xin H, Chen H, et al. The SAT1\/ALOX15 signaling pathway is involved in ferroptosis after skeletal muscle contusion. Int J Mol Sci. 2024;25:11317.","DOI":"10.3390\/ijms252011317"},{"key":"8898_CR33","doi-asserted-by":"crossref","unstructured":"Dang Y, He Q, Yang S, Sun H, Liu Y, Li W, et al. FTH1- and SAT1-induced astrocytic ferroptosis is involved in alzheimer\u2019s disease: evidence from single-cell transcriptomic analysis. Pharmaceuticals. 2022;15:1177.","DOI":"10.3390\/ph15101177"},{"key":"8898_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176820","volume":"979","author":"X Ren","year":"2024","unstructured":"Ren X, Wen Y, Yuan M, Li C, Zhang J, Li S, et al. Cerebroprotein hydrolysate-I ameliorates cognitive dysfunction in APP\/PS1 mice by inhibiting ferroptosis via the p53\/SAT1\/ALOX15 signalling pathway. Eur J Pharm. 2024;979:176820.","journal-title":"Eur J Pharm"},{"key":"8898_CR35","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci USA. 2016;113:E6806\u2013E12.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8898_CR36","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41556-025-01668-z","volume":"27","author":"ML Sassano","year":"2025","unstructured":"Sassano ML, Tyurina YY, Diokmetzidou A, Vervoort E, Tyurin VA, More S, et al. Endoplasmic reticulum-mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis. Nat Cell Biol. 2025;27:902\u201317.","journal-title":"Nat Cell Biol"},{"key":"8898_CR37","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1007\/s12035-023-03463-z","volume":"60","author":"K Wan","year":"2023","unstructured":"Wan K, Jia M, Zhang H, Lan Y, Wang S, Zhang K, et al. Electroacupuncture alleviates neuropathic pain by suppressing ferroptosis in the dorsal root ganglion via SAT1\/ALOX15 Signaling. Mol Neurobiol. 2023;60:6121\u201332.","journal-title":"Mol Neurobiol"},{"key":"8898_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1302\/2046-3758.133.BJR-2023-0250.R1","volume":"13","author":"J Xu","year":"2024","unstructured":"Xu J, Ruan Z, Guo Z, Hou L, Wang G, Zheng Z, et al. Inhibition of SAT1 alleviates chondrocyte inflammation and ferroptosis by repressing ALOX15 expression and activating the Nrf2 pathway. Bone Jt Res. 2024;13:110\u201323.","journal-title":"Bone Jt Res"},{"key":"8898_CR39","doi-asserted-by":"crossref","unstructured":"Li YC, Cheng ML. Carvedilol confers ferroptosis resistance in HL-1 cells by upregulating GPX4, FTH1, and FTL1 and inducing metabolic remodeling under hypoxia\/reoxygenation. Antioxidants. 2024;14:7.","DOI":"10.3390\/antiox14010007"},{"key":"8898_CR40","doi-asserted-by":"crossref","unstructured":"Punziano C, Trombetti S, Cesaro E, Grosso M, Faraonio R. Antioxidant systems as modulators of ferroptosis: focus on transcription factors. Antioxidants. 2024;13:298.","DOI":"10.3390\/antiox13030298"},{"key":"8898_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1681\/ASN.2019060570","volume":"31","author":"E Mishima","year":"2020","unstructured":"Mishima E, Sato E, Ito J, Yamada KI, Suzuki C, Oikawa Y, et al. Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. J Am Soc Nephrol. 2020;31:280\u201396.","journal-title":"J Am Soc Nephrol"},{"key":"8898_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2006.08.009","volume":"10","author":"D Trachootham","year":"2006","unstructured":"Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006;10:241\u201352.","journal-title":"Cancer Cell"},{"key":"8898_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372.","journal-title":"Physiol Rev"},{"key":"8898_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/antiox14010007","volume":"14","author":"Y-C Li","year":"2025","unstructured":"Li Y-C, Cheng M-L. Carvedilol confers ferroptosis resistance in HL-1 cells by upregulating GPX4, FTH1, and FTL1 and inducing metabolic remodeling under Hypoxia\/reoxygenation. Antioxidants. 2025;14:7.","journal-title":"Antioxidants"},{"key":"8898_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70607","volume":"39","author":"NZ Abuelezz","year":"2025","unstructured":"Abuelezz NZ, Ahmed MK, Abd El Aziz AE, El Sayed NS. Carvedilol confers neuroprotective activity through modulating ferroptosis key players and PINK1\/PARKIN-mediated mitophagy in an experimental Parkinson\u2019s rat model. J Biochem Mol Toxicol. 2025;39:e70607.","journal-title":"J Biochem Mol Toxicol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08898-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:05:17Z","timestamp":1784081117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08898-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8898"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08898-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. This study was approved by the Biomedical Research Ethics Committee of Shandong Provincial Hospital (No. NSFC 2023-314).","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"641"}}